As of May 24
| +0.75 / +5.66%|
The 4 analysts offering 12-month price forecasts for GlycoMimetics Inc have a median target of 12.50, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a -10.71% decrease from the last price of 14.00.
The current consensus among 5 polled investment analysts is to Buy stock in GlycoMimetics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.